Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Drug Resistance

  Free Subscription


26.02.2018

2 AIDS
2 Infect Control Hosp Epidemiol
4 Int J Antimicrob Agents
1 J Antimicrob Chemother
4 J Med Microbiol
2 Lancet Infect Dis
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    PubMed     Text format     Abstract available

  2. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    PubMed     Text format     Abstract available


    Infect Control Hosp Epidemiol

  3. STEIN C, Tittelbach J, Monecke S, Weis S, et al
    Rethinking the Molecular Diagnostics for Methicillin-Resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol. 2018 Feb 21:1-2. doi: 10.1017/ice.2018.
    PubMed     Text format    

  4. PEDELA RL, Shihadeh KC, Knepper BC, Haas MK, et al
    Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System.
    Infect Control Hosp Epidemiol. 2017;38:461-468.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  5. WI YM, Choi JY, Lee JY, Kang CI, et al
    Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Int J Antimicrob Agents. 2017;49:767-769.
    PubMed     Text format     Abstract available

  6. LIANG Q, Yin Z, Zhao Y, Liang L, et al
    Sequencing and comparative genomics analysis of the IncHI2 plasmids pT5282-mphA and p112298-catA and the IncHI5 plasmid pYNKP001-dfrA.
    Int J Antimicrob Agents. 2017;49:709-718.
    PubMed     Text format     Abstract available

  7. DAHDOUH E, Gomez-Gil R, Sanz S, Gonzalez-Zorn B, et al
    A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017;49:727-733.
    PubMed     Text format     Abstract available

  8. LI QJ, Jiao WW, Yin QQ, Li YJ, et al
    Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.
    Int J Antimicrob Agents. 2017;49:757-762.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  9. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Microbiol

  10. SAKSENA R, Gaind R, Sinha A, Kothari C, et al
    High prevalence of fluoroquinolone resistance amongst commensal flora of antibiotic naive neonates: a study from India.
    J Med Microbiol. 2018 Feb 6. doi: 10.1099/jmm.0.000686.
    PubMed     Text format     Abstract available

  11. KIM JH, Kim TS, Song SH, Choi J, et al
    Direct rapid antibiotic susceptibility test (dRAST) for blood culture and its potential usefulness in clinical practice.
    J Med Microbiol. 2018 Jan 12. doi: 10.1099/jmm.0.000678.
    PubMed     Text format     Abstract available

  12. OSAKA S, Okuzumi K, Koide S, Tamai K, et al
    Genetic shifts in methicillin-resistant Staphylococcus aureus epidemic clones and toxin gene profiles in Japan: comparative analysis among pre-epidemic, epidemic and post-epidemic phases.
    J Med Microbiol. 2018 Feb 2. doi: 10.1099/jmm.0.000687.
    PubMed     Text format     Abstract available

  13. SONG Q, Wu J, Ruan P
    Predominance of community-associated sequence type 59 methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit.
    J Med Microbiol. 2018 Feb 5. doi: 10.1099/jmm.0.000693.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  14. PAUL M, Daikos GL, Durante-Mangoni E, Yahav D, et al
    Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
    Lancet Infect Dis. 2018 Feb 15. pii: S1473-3099(18)30099.
    PubMed     Text format     Abstract available

  15. PEREZ F, Bonomo RA
    Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria.
    Lancet Infect Dis. 2018 Feb 15. pii: S1473-3099(18)30112.
    PubMed     Text format    


    PLoS One

  16. SIGAUQUE B, Kobayashi M, Vubil D, Nhacolo A, et al
    Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
    PLoS One. 2018;13:e0191193.
    PubMed     Text format     Abstract available

  17. LEE HJ, Kim SJ, Kweon YO, Park SY, et al
    Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.
    PLoS One. 2018;13:e0190581.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: